Wanbangde Pharmaceutical Holding Group Co Ltd Cash Flow Reinvestment Rate
Wanbangde Pharmaceutical Holding Group Co Ltd cash flow reinvestment rate. Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a Cash Flow Reinvestment Rate of 2.60x as of June 2025, reinvesting CN¥159.76 Million (capex CN¥153.03 Million plus investments CN¥6.73 Million) from operating cash flow of CN¥61.33 Million. See 002082 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)
Cash flow reinvestment rate of Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2025. Historical reinvestment intensity for Wanbangde Pharmaceutical Holding Group Co Ltd across 18 annual periods. Explore Wanbangde Pharmaceutical Holding Group C cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Wanbangde Pharmaceutical Holding Group Co Ltd Cash Flow Reinvestment Rate by Year (2003–2025)
Wanbangde Pharmaceutical Holding Group Co Ltd cash flow reinvestment rate by year from 2003 to 2025. Year-by-year capital reinvestment analysis for Wanbangde Pharmaceutical Holding Group Co Ltd. For the full cash flow conversion analysis, see Wanbangde Pharmaceutical Holding Group C cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | CN¥297.81 Million | CN¥603.98 Million | CN¥289.65 Million | ▼ -69.9% |
| 2024 | 1.64x | CN¥197.22 Million | CN¥120.22 Million | CN¥88.43 Million | ▼ -97.2% |
| 2021 | 57.80x | CN¥1.28 Billion | CN¥22.09 Million | CN¥277.06 Million | ▲ +1357.0% |
| 2020 | 3.97x | CN¥599.04 Million | CN¥151.01 Million | CN¥559.24 Million | ▲ +142.1% |
| 2018 | 1.64x | CN¥221.87 Million | CN¥135.40 Million | CN¥199.64 Million | ▲ +4926.7% |
| 2016 | 0.03x | CN¥10.13 Million | CN¥310.71 Million | CN¥9.03 Million | ▼ -98.2% |
| 2015 | 1.82x | CN¥30.47 Million | CN¥16.76 Million | CN¥30.47 Million | ▲ +467.9% |
| 2014 | 0.32x | CN¥44.91 Million | CN¥140.31 Million | CN¥44.91 Million | ▲ +502.5% |
| 2013 | 0.05x | CN¥12.45 Million | CN¥234.35 Million | CN¥12.45 Million | ▼ -73.7% |
| 2012 | 0.20x | CN¥40.92 Million | CN¥202.73 Million | CN¥40.92 Million | ▼ -25.6% |
| 2010 | 0.27x | CN¥44.02 Million | CN¥162.26 Million | CN¥44.02 Million | ▼ -69.2% |
| 2009 | 0.88x | CN¥60.02 Million | CN¥68.13 Million | CN¥60.02 Million | ▲ +51.7% |
| 2008 | 0.58x | CN¥146.92 Million | CN¥253.06 Million | CN¥146.92 Million | ▼ -93.4% |
| 2007 | 8.81x | CN¥109.68 Million | CN¥12.45 Million | CN¥109.68 Million | ▼ -67.0% |
| 2006 | 26.70x | CN¥93.47 Million | CN¥3.50 Million | CN¥93.47 Million | ▲ +241.2% |
| 2005 | 7.83x | CN¥87.86 Million | CN¥11.23 Million | CN¥87.86 Million | ▲ +160.2% |
| 2004 | 3.01x | CN¥98.30 Million | CN¥32.69 Million | CN¥98.30 Million | ▲ +193.5% |
| 2003 | 1.02x | CN¥37.92 Million | CN¥37.01 Million | CN¥37.92 Million | — |